NCT05238883
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05238883
Title A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors HiFiBiO Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Mayo Clinic Scottsdale Arizona 85259 United States Details
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Mayo Clinic Jacksonville Florida 32224 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Washington University School of Medicine St Louis Missouri 63110 United States Details
The University of Texas, MD Anderson Cancer Center Houston Texas 77030 United States Details
NEXT Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
Hospital Universitario Vall d'Hebron Barcelona 08035 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Hospital Clinico Universitario de Valencia Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field